UK government targets manufacturing as it eyes £41bn life science sector growth
With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.

With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
AI in drug discovery: from hypothetical to reality
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act